Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : TRB-1
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Preclinical
Sponsor : Recipharm AB
Deal Size : Undisclosed
Deal Type : Agreement
Transpire Bio Announces Agreement with Recipharm for The Development of An Inhaled Medicine
Details : Recipharm is developing and commercializing inhalation technologies and products in support of the development and advancement of Transpire Bio’s TRB-1 and TRB-2 respiratory products.
Brand Name : TRB-1
Molecule Type : Small molecule
Upfront Cash : Undisclosed
July 14, 2022
Lead Product(s) : TRB-1
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Preclinical
Sponsor : Recipharm AB
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?